CollPlant Biotechnologies Ltd.
CLGN
$2.62
-$0.0066-0.25%
NASDAQ
06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
---|---|---|---|---|---|
Revenue | 179.00K | 164.00K | 249.00K | 98.00K | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 179.00K | 164.00K | 249.00K | 98.00K | |
Cost of Revenue | 186.00K | 272.00K | 536.00K | 545.00K | |
Gross Profit | -7.00K | -108.00K | -287.00K | -447.00K | |
SG&A Expenses | 1.16M | 1.32M | 1.42M | 1.48M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 3.36M | 4.14M | 4.66M | 4.43M | |
Operating Income | -3.18M | -3.97M | -4.41M | -4.33M | |
Income Before Tax | -3.35M | -3.88M | -4.21M | -4.20M | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -3.35M | -3.88M | -4.21M | -4.20M | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -3.35M | -3.88M | -4.21M | -4.20M | |
EBIT | -3.18M | -3.97M | -4.41M | -4.33M | |
EBITDA | -2.95M | -3.73M | -4.15M | -4.05M | |
EPS Basic | -0.28 | -0.34 | -0.37 | -0.37 | |
Normalized Basic EPS | -0.18 | -0.21 | -0.23 | -- | |
EPS Diluted | -0.28 | -0.34 | -0.37 | -0.37 | |
Normalized Diluted EPS | -0.18 | -0.21 | -0.23 | -- | |
Average Basic Shares Outstanding | 11.84M | 11.45M | 11.45M | 11.45M | |
Average Diluted Shares Outstanding | 11.84M | 11.45M | 11.45M | 11.45M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |